| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GNPX | Genprex, Inc. | Berger Mark Stanley | Chief Medical Officer | Feb 18, 2024 | Option Exercise | $4.40 | 1,319 | 5,804 | 4,806 | Feb 21, 2024, 04:34 PM | |
| ATNM | Actinium Pharmaceuticals, Inc. | Berger Mark Stanley | Chief Medical Officer | Mar 05, 2019 | Option Exercise | $0.60 | 3,500 | 2,100 | 22,500 | Mar 07, 2019, 04:15 PM | |
| ATNM | Actinium Pharmaceuticals, Inc. | Berger Mark Stanley | Chief Medical Officer | Mar 06, 2018 | Option Exercise | $0.50 | 14,000 | 7,000 | 19,000 | Mar 19, 2018, 05:04 PM | |
| ATNM | Actinium Pharmaceuticals, Inc. | Berger Mark Stanley | Chief Medical Officer | Jun 15, 2017 | Buy | $1.11 | 5,000 | 5,550 | 5,000 | Jun 15, 2017, 04:56 PM |
Menu